Several changes to the Scientific Sessions program instituted last year proved popular and will return this year, including the four-day meeting format and shorter sessions. The program also features multiple session formats to facilitate engagement, including symposia, debates, Ask the Expert sessions, panel discussions, and professional development presentations.

“When people come to these meetings, they are able to connect, ask questions, and hear different perspectives,” said Marlon Pragnell, PhD, ADA Vice President of Research & Science. “What we try to have throughout the whole program is this opportunity for people to become engaged and not just listen.”

Two Ask the Expert session are available during the 84^th Scientific Sessions taking place June 21-24 at the Orange County Convention Center. On Friday, How Will Artificial Intelligence Change Clinical Practice? will begin at 2 p.m. ET and includes a livestream. On Monday, The Highs and Lows of Cannabis Use in Diabetes—Behavioral and Psychosocial Considerations will begin at 3:15 p.m.

Ten debates are on the schedule.

• Friday, 12:45 p.m.: Race and Ethnicity-Based Cut Points in Diabetes Screening and Diagnosis—Benefit or Harm for Reducing Disparities? (includes livestream)
• Friday, 12:45 p.m.: Setting the Record Straight—Does SARS-CoV-2 Cause Type 1 Diabetes? (includes livestream)
• Friday, 5:30 p.m.: Sulfonylureas in Type 2 Diabetes Management—Should They Stay or Should They Go? (includes livestream)
• Saturday, 1:30 p.m.: Innovation or Access in Diabetes Technology—What Should Be Our Global Priority?
• Saturday, 3:15 p.m.: Boosting Energy Expenditure in Obesity—Debating the Potential of Thermogenic Adipose Tissue and Skeletal Muscle Bioenergetics as Antiobesity Targets in Humans
• Saturday, 3:15 p.m.: Diabetes Prevention Program (DPP) vs GLP-1RA—Which Tool Is Best to Battle the Obesity and Diabetes Epidemics?
• Sunday, 1:30 p.m.: The Role of Artificial Intelligence in Transforming Nutrition and Diabetes Care—Ready for Prime Time or Not Quite?
• Sunday, 4:30 p.m.: Keeping Up with Hollywood—Who Should Be Prioritized for New Antiobesity Medications?
• Monday, 3:15 p.m.: Do Immune or Beta Cells Drive Transition from Stage 1 to Stage 3 Type 1 Diabetes?
• Monday, 3:15 p.m.: Early Abnormal Glucose Metabolism in Pregnancy—To Treat or Not To Treat

A Keynote Address, special lectures, and award lectures round out the lineup. 

• Friday, 10:30 a.m.: Welcome to the 84th ADA Scientific Sessions—Keynote Address and Panel Discussion, Robert A. Gabbay, MD, and Robert M. Califf, MD (includes livestream)
• Saturday, 9:45 a.m.: ADA Chief Executive Officer Remarks, Charles D. Henderson; President, Health Care & Education Address, Lessons Learned—Diabetes Education for One and for All, Patti Urbanski, Med, RD, LD, CDCES, FADCES; and Outstanding Educator in Diabetes Award Lecture, Meeting People Where They Are—Improving Diabetes Care and Outcomes through Education and Collaboration, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP (includes livestream)
• Sunday, 9:45 a.m.: President, Medicine & Science Address and National Scientific & Health Care, Fighting Diabetes—A Journey that Began in Childhood, Mandeep Bajaj, MBBS; and Achievement Awards Presentation (includes livestream)
• Sunday, 3:15 p.m.: Kelly West Award for Outstanding Achievement in Epidemiology Lecture, Lessons Learnt from Epidemiology of Diabetes in South Asians, Viswanathan Mohan, MD, PhD, DSc, FRCP, FNA, FACE, MACP, FRSE (includes livestream)
• Monday, 9:45 a.m.: Outstanding Scientific Achievement Award Lecture, Insulin and Instruction—How the Epigenome Directs Diabetes, Stephen CJ Parker, PhD; and Banting Medal for Scientific Achievement Award Lecture, The Science of Diabetes and a Life of Trials, Rury R. Holman, MBChB, FRCP(Lond), FMedSci (includes livestream)

Information on additional sessions, including symposia and panel discussions, is available in the Online Planner.